Opportunity ID: 90414

General Information

Document Type: Grants Notice
Funding Opportunity Number: W81XWH-11-TSCRP-IDA
Funding Opportunity Title: DOD Tuberous Sclerosis Complex Idea Development Award
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Grant
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 3
Assistance Listings: 12.420 — Military Medical Research and Development
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Apr 28, 2011
Last Updated Date:
Original Closing Date for Applications: Aug 01, 2011
Current Closing Date for Applications: Aug 01, 2011
Archive Date: Aug 31, 2011
Estimated Total Program Funding: $2,700,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: Dept. of the Army — USAMRAA
Description: The Tuberous Sclerosis Complex Research Program (TSCRP) was established in 2002 to promote innovative research focused on decreasing the clinical impact of tuberous sclerosis complex (TSC). The mission of the TSCRP is to encourage innovative research aimed at understanding the pathogenesis of TSC and to translate these findings to the care of individuals with TSC. The FY11 TSCRP Idea Development Award supports high-impact, innovative research that will drive the field of TSC research forward. Preclinical studies are encouraged but clinical trials are not allowed. Important aspects of the Idea Development Award are as follows: The proposed research should have a significant impact on the concepts or methods that drive the field of TSC research. The proposed research is expected to make an important and original contribution to advancing TSC research and/or patient care. Research deemed innovative may represent a new paradigm, challenge existing paradigms, or look at existing problems from new perspectives or exhibit other uniquely creative qualities. Research may be innovative in study concept, research methods or technology, clinical interventions, or adaptations of existing methods or technologies. Research that represents an incremental advance on previously published work is not considered innovative. Preliminary data should be included that is relevant to the proposed project. The FY11 TSCRP strongly supports collaborative research between basic scientists and clinical researchers, and between academic scientists and biotechnology/pharmaceutical industry scientists. Collaborations that bring new perspectives from other disciplines or bring new investigators into the TSC field are also strongly encouraged.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

PA HELP: 301-682-5507; help@cdmrp.org

eReceipt HELP: 301-682-5507; help@cdmrp.org

Email:help@cdmrp.org

Version History

Version Modification Description Updated Date

Folder 90414 Full Announcement-1 -> tscrp_fy11 ida pa_gg.pdf

Packages

Agency Contact Information: PA HELP: 301-682-5507; help@cdmrp.org
eReceipt HELP: 301-682-5507; help@cdmrp.org

Email: help@cdmrp.org

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
12.420 PKG00050612 Apr 28, 2011 Aug 01, 2011 View

Package 1

Mandatory forms

90414 RR_SF424_1_2-1.2.pdf

90414 PerformanceSite_1_4-1.4.pdf

90414 RR_Budget-1.1.pdf

90414 RR_KeyPersonExpanded_1_2-1.2.pdf

Optional forms

90414 RR_SubawardBudget30-1.2.pdf

2025-07-13T03:34:28-05:00

Share This Post, Choose Your Platform!

About the Author: